| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |